High-Flow nasal cannula treatment in patients with COVID-19 acute hypoxemic respiratory failure: A prospective cohort study

High-Flow nasal cannula treatment in patients with COVID-19 acute hypoxemic respiratory failure: A prospective cohort study

Background: Early use of high-flow nasal cannula (HFNC) decreases the need for endotracheal intubation (EI) in different respiratory failure causes. While HFNC is used in coronavirus disease 2019 (COVID-19)-related acute hypoxemic respiratory failure (AHRF) under weak recommendations, its efficacy r...

Full description

Bibliographic Details
Main Authors: Mohammed S Alshahrani, Hassan M Alshaqaq, Jehan Alhumaid, Ammar A Binammar, Khalid H AlSalem, Abdulazez Alghamdi, Ahmed Abdulhady, Moamen Yehia, Amal AlSulaibikh, Mohammed Al Jumaan, Waleed H Albuli, Talal Ibrahim, Abdullah A Yousef, Yousef Almubarak, Waleed Alhazzani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Saudi Journal of Medicine and Medical Sciences
Subjects:
acute hypoxemic respiratory failure
covid-19
endotracheal intubation
high-flow nasal cannula
oxygen therapy
sars-cov-2
Online Access:http://www.sjmms.net/article.asp?issn=1658-631X;year=2021;volume=9;issue=3;spage=215;epage=222;aulast=Alshahrani

Internet

http://www.sjmms.net/article.asp?issn=1658-631X;year=2021;volume=9;issue=3;spage=215;epage=222;aulast=Alshahrani

Similar Items